LXRP - Lexaria Bioscience Corp.

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 565.08M
Enterprise Value 364.07M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)237.29
Price/Book (mrq)23.06
Enterprise Value/Revenue 3233.61
Enterprise Value/EBITDA 6-9.88

Financial Highlights

Fiscal Year

Fiscal Year Ends Aug 31, 2018
Most Recent Quarter (mrq)Feb 28, 2019


Profit Margin 0.00%
Operating Margin (ttm)-2,369.02%

Management Effectiveness

Return on Assets (ttm)-114.15%
Return on Equity (ttm)-198.81%

Income Statement

Revenue (ttm)274.25k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)-91.10%
Gross Profit (ttm)395.14k
Net Income Avi to Common (ttm)-6.49M
Diluted EPS (ttm)-0.0870
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)3.16M
Total Cash Per Share (mrq)0.04
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)7.28
Book Value Per Share (mrq)0.04

Cash Flow Statement

Operating Cash Flow (ttm)-2.56M
Levered Free Cash Flow (ttm)-597.55k

Trading Information

Stock Price History

Beta (3Y Monthly) 2.89
52-Week Change 3-59.57%
S&P500 52-Week Change 38.59%
52 Week High 32.2400
52 Week Low 30.7500
50-Day Moving Average 30.9212
200-Day Moving Average 31.1367

Share Statistics

Avg Vol (3 month) 395.48k
Avg Vol (10 day) 350.28k
Shares Outstanding 578.39M
Float 61.35M
% Held by Insiders 119.98%
% Held by Institutions 12.11%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/1
Last Split Date 3Dec 16, 2015